
Verismo will pair Stanford's PACK-IT lentiviral technology with its KIR-CAR platform to pursue off-the-shelf, in vivo CAR T therapies for cancer.
This quiz measures your comprehension of one of our recent feature articles.
A. To streamline the regulatory approval process by prioritizing formulations with the longest shelf life.






